Angiotensin-converting enzyme 2 (ACE2), a carboxypeptidase that is highly homologous to ACE, acts as a negative regulator for the renin-angiotensin system (RAS). Pancreatic RAS is thought to play important endocrine and exocrine roles in hormone secretion. Further exploration of this system is likely to offer new insights into the pathogenesis of pancreatic diseases such as diabetes mellitus. This study investigated the expression of ACE2 in rat pancreatic exocrine and endocrine tissue. Reverse transcription-polymerase chain reaction, immunoblotting and immunohisto chemistry showed that ACE2 mRNA and protein were expressed in the pancreas. Immunoelectron microscopy demonstrated that ACE2 was expressed in both endocrine and exocrine pancreatic tissues. In the endocrine tissue, ACE2 was localized on the secretory granules. Double immunofluorescence labelling showed that ACE2 was co-localized with both insulin and somatostatin, while it was rarely co-localized with glucagon and pancreatic polypeptide. These findings suggest that ACE2 might play an important role in glucose homeostasis. The authors had no conflicts of interest to declare in relation to this article. 568 HJ Fang, JK Yang Pancreatic expression of angiotensin-converting enzyme 2 associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203: 622 -630. 27 Yang JK, Lin SS, Ji XJ, et al: Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2009; e-pub ahead of print.
Introduction
The systemic renin-angiotensin system (RAS) has been recognized for many years as playing a critical role in regulating blood pressure, electrolyte and fluid homeostasis. 1 Although most of the well-known effects of the RAS are attributed to angiotensin-converting enzyme (ACE), much less is known about the function of angiotensin-converting enzyme 2 (ACE2). The fact that ACE2 generates the vasodilator angiotensin 1-7 suggests that it acts as a further counterbalancing tissue-specific mechanism within the activated RAS. 2 Experiments using genetically-modified mice and inhibitor studies have shown that ACE2 counterbalances the functions of ACE and that the balance between these two proteases determines local and systemic levels of RAS peptides such as angiotensin II and angiotensin 1-7. 3 ACE2 mutant mice exhibit progressive impairment of heart contractility at advanced ages, a phenotype that can be reversed by loss of ACE, suggesting that these enzymes directly control heart function. 4 Moreover, ACE2 is also found to be up-regulated in failing HJ Fang, JK Yang Pancreatic expression of angiotensin-converting enzyme 2 hearts. 5 In the kidney, ACE2 protein levels are significantly decreased in hypertensive rats, suggesting a negative regulatory role of ACE2 in blood pressure control. 6 ACE2 mutant mice develop late-onset glomerulonephritis resembling diabetic nephropathy 7 and ACE2 expression is downregulated in both the glomeruli and proximal tubules of diabetic patients. 8 In a previous study, impaired glucose tolerance was observed in ACE2 gene knockout mice that were characterized by reduced insulin secretion in the first phase. 9 Thus, ACE2 seems to be a molecule that plays a protective role in cardiovascular diseases, hypertension and pancreatic diseases.
Initially ACE2 was found to be expressed in the endothelia of the heart 10 and in tubular epithelial cells of the kidney. 11 Harmer et al. 12 examined the expression profile of ACE2 mRNA in 72 human tissues and confirmed its expression in the bronchus, lung parenchyma, ileum, testis, and in cardiovascular, renal and gastrointestinal tissues, and in the pancreas. A study investigating the localization of ACE2 protein in 15 human organs found that ACE2 was also abundantly present in the epithelia of the lung and small intestine. 13 Although several studies have confirmed ACE2 expression in the pancreas, none of them measured the expression of ACE2 separately in the exocrine and endocrine pancreas, particularly its location within the islets of Langerhans. Thus, the visualization of ACE2 expression in the pancreatic islets by a method such as immunohistochemical staining would increase knowledge in this area.
To test for the existence of a local RAS, it is essential to demonstrate that all components are not derived from the circulation but are locally generated. To this end, we undertook an investigation at tissue and cellular levels. At the tissue level, ACE2 protein level was assessed by immunoblotting and immunohistochemistry. In addition, ACE2 mRNA expression was measured using reverse transcription-polymerase chain reaction (RT-PCR). At the cellular level, ACE2 protein level was assessed using double immunofluorescence labelling and immunoelectron microscopy. By studying ACE2 expression, the aim of the present study was to provide further evidence on the pathological and physiological significance of ACE2 in pancreatic diseases.
Materials and methods

TISSUES
Wistar rats (4 weeks old) with a mean weight of 200 g were used in the study. After anaesthetization, the pancreas was promptly removed and immediately fixed in Bouin's solution for 24 h. The pancreatic tissue specimens for immunohistochemistry and immunofluorescence were formalin-fixed, embedded in paraffin, cut into 4 µm serial successive sections and placed onto glass microscope slides. Specimens for immunoelectron microscopy were fixed in 4% periodate-lysine-paraformaldehyde (PLP) overnight at 4°C. These were subsequently washed in 0.1 M phosphate buffered saline (PBS) pH 7.4 containing 10% sucrose for 4 h, then cryoprotected in 0.1 M PBS containing 15% sucrose for 4 h and in 0.1 M PBS containing 20% sucrose for 4 h. The tissues were embedded in Optimal Cutting Temperature compound (Lab-Tek Products, Naperville, IL, USA) and immediately quick frozen in liquid nitrogen, where they remained until analysis. All animal experiments followed the national ethical guidelines implemented by the Animal Care and Use Committee at Beijing Tongren Hospital, Capital Medical University, Beijing, China, which have been approved by the local authorities.
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After anaesthesia by one intraperitoneal injection of chloral hydrate (400 mg/kg), the pancreas and kidney tissues were removed rapidly and frozen in liquid nitrogen. Total RNA was isolated using TRIzol ® reagent (Promega, Madison, WI, USA) and reverse transcribed to cDNA using the QuantiTect ® Reverse Transcription Kit (Qiagen, Chatsworth, Germany) according to the manufacturer's instructions. The primers were designed using Prime 5.0 software based on the cDNA sequence of the rat ACE2 gene (NM_001012006) obtained from Genbank ® (National Center for Biotechnology Information, US National Library of Medicine, Bethesda, MD, USA). The primers were synthesized by Sangon (Shanghai, China). The primers for ACE2 were 5′-AGT GGA TGG GAT CTT GGC GCA-3′ (forward) and 5′-CTT AGA ATG AAG TTT GAG CAT CAT CA-3′ (reverse), and the amplicon was 2438 bp. The cDNA was synthesized with or without (negative control) reverse transcriptase in parallel. Rat cDNAs were used as templates for the PCR amplification using the following reaction mix: 1 µg cDNA (1 µl), 10 µM each of the forward and reverse primers (1.5 µl each), 50 mM MgSO 4 (1 µl), 10 µM deoxynucleotide triphosphate (1.5 µl; Invitrogen Life Science, Carlsbad, CA, USA), 10× Platinum ® Pfx Amplification Buffer (5 µl; Invitrogen Life Science), 2.5 U/µl Platinum ® Pfx DNA polymerase (0.6 µl; Invitrogen Life Science), and RNase-free H 2 O 37.9 µl. The PCR reaction was carried out as follows: 5 min of initial denaturation at 95°C, 30 cycles of 30 s denaturation at 94°C, 30 s annealing at 60°C, 2.5 min extension at 72°C, followed by a final 10 min extension at 72°C. The RT-PCR amplification products were electrophoresed using 1% agarose gel and inspected under a UV light source. Gene sequence analysis was performed by the Sino Gene Company (Beijing, China).
IMMUNOBLOTTING
Total protein was extracted from rat pancreatic tissue using a Total Protein Extraction Kit (Millipore, Billerica, MA, USA), and the supernatant was collected from the tissue homogenates after centrifugation for 15 min at 12 000 g. The proteins were lysed in 1 × sodium dodecyl sulphate-poly acrylamide gel electrophoresis (SDS-PAGE) loading buffer, pH 6.8, and boiled in a water bath for 10 min. The protein concentrations were determined by the bicinchoninic acid (BCA) method. A total of 30 µg protein was resolved using SDS-PAGE (10% gel) and electrophoretically transferred onto a nitrocellulose membrane. After blocking with TBST (Tris-HCl 10 mmol/l pH 7.5, NaCl 100 mmol/l, 0.1% Tween-20) containing 5% non-fat milk, membranes were incubated with a primary rabbit antihuman ACE2 polyclonal antibody (1:200 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. As a control, a second membrane was incubated in TBST alone without primary antibody. Membranes were washed three times in TBST and then incubated at 37°C for 1 h with a corresponding secondary antibody (horseradish peroxidase [HRP]-conjugated antirabbit immunoglobulin G [IgG]; Santa Cruz Biotechnology) diluted 1:2000 in TBST containing 5% non-fat milk. Membranes were washed a final three times in TBST for 10 min. The target protein bands were detected by the enhanced chemi luminescence (ECL) method using an ECL Kit (SC-2048; Santa Cruz Biotechnology) according to the manufacturer's instructions. The glyceraldehyde 3-phosphate dehydrogenase protein level was measured as a loading control.
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Only slides of 'morphologically normal' pancreatic tissue were studied. Paraffin sections were deparaffinized in xylene and rehydrated. Endogenous peroxidase was blocked with 0.3% H 2 O 2 in 70% methanol for 10 min. Non-specific binding of secondary antibodies was blocked by incubation for 30 min with normal goat serum. Incubation with primary polyclonal goat antihuman ACE2 antibody (1:100 dilution; Santa Cruz Biotechnology) was performed overnight at 4°C in a humidified chamber. Negative control tests were performed to determine the specificity of the antibody: sections were incubated in 0.01 mM PBS, pH 7.4, without the primary antibody. After washing three times in 0.01 mM PBS, sections were incubated with the secondary biotin-labelled rabbit antigoat antibody (Histostain ® -SP kit; Zymed Laboratories, San Francisco, USA) at 37°C for 30 min, washed a final three times in 0.01 mM PBS, then incubated with streptavidinhorseradish peroxidase at 37°C for 20 min. Peroxidase activity was detected using the diaminobenzidine (DAB) technique (Dako Liquid DAB Substrate-Chromogen System; Dako, Glostrup, Denmark), according to the manufacturer's instruction, and nuclei (when necessary) were counterstained with 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI) (Roche Molecular Diagnostics, Pleasanton, CA, USA).
IMMUNOELECTRON MICROSCOPY
Immunoelectron microscopy was used to study the localization of ACE2 in the normal rat pancreas. The tissues fixed in PLP were frozen, 4 µm sections were cut and placed on albumin-coated microscope glass slides and air dried. They were dehydrated with a graded series of ethanol and then twice in propylene oxide for 15 min and embedded in araldite (Araldite 502 kit; Electron Microscopy Sciences, Hatfield, PA, USA) overnight at 60°C. The sections were incubated for 30 min at room temperature in 1.5% bovine serum albumin (BSA; Sigma-Aldrich, St Louis, MO, USA) in 0.01 M PBS to block the slides, then incubated with goat antihuman polyclonal ACE2 antibody (Santa Cruz Biotechnology) at a concentration of 1:100 in 0.01 M PBS. The sections of the control group were incubated with 0.01 M PBS containing 1.5% BSA only. All sections were incubated overnight at 4°C in a humid chamber and then at 37°C for 1 h. The sections were washed three times for 10 min in 0.05 M Tris-buffered saline (TBS), pH 7.4, then once for 10 min in 0.02 M TBS pH 7.4. The sections were again blocked for 30 min at room temperature in 1.5% BSA in PBS and then incubated with a goldconjugated secondary rabbit antigoat IgG antibody (10 nm gold particles; Sigma-Aldrich), diluted 1:40 in 0.01 M PBS, for 1 h at 37°C. The sections were washed three times for 10 min in water and stained with 2 % uranyl acetate (in water) at room temperature for 30 min and with lead citrate for 30 min. Lastly, the specimens were examined and photographed under a transmission electron microscope (JEOL JEM-1230; JEOL, Tokyo, Japan).
DOUBLE-IMMUNOFLUORESCENCE LABELLING
Formalin-fixed, paraffin-embedded blocks of rat pancreas, cut into 4 µm sections, were examined by double immunofluorescence labelling. Non-specific binding of the secondary antibody was blocked by incubation for 30 min at room temperature with normal donkey serum. Sections were incubated for 24 h in a mixture of goat antihuman ACE2 polyclonal IgG antibody (Santa Cruz Biotechnology) and one of the 
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HJ Fang, JK Yang Pancreatic expression of angiotensin-converting enzyme 2 following polyclonal antibodies against pancreatic hormones (insulin, glucagon, somatostatin and pancreatic polypeptide) at the dilutions shown in Table 1 . The sections were rinsed three times with 0.01 mM PBS and incubated in a cocktail consisting of two secondary antibodies, Alexa Fluor ® 488 donkey antirabbit IgG (H+L) (1:200 dilution; emission peak, 519 nm; Molecular Probes, Eugene, OR, USA) and Alexa Fluor ® 594 donkey antigoat IgG (H+L) (1:200; emission peak, 613 nm; Molecular Probes), in the dark for 1 h. Immunofluorescence of ACE2 was visualized by the red colour of Texas Red and the reactivity of the antibodies directed against each hormone was visualized by the green fluorescence of fluorescein isothiocyanate. The tissue sections were coverslipped using Vectashield ® mounting medium (Vector Laboratories Inc., Burlingame, CA, USA) containing 1.5 µg/ml DAPI as a nuclear counterstain. The pancreatic specimens were examined using a laser scanning confocal microscope (LSM510; Carl Zeiss, Jena, Germany) with an attached digital camera (AxioCam; Carl Zeiss, Oberkochen, Germany).
Results
ACE2 MRNA EXPRESSION MEASURED BY RT-PCR
To examine ACE2 mRNA expression in pancreatic and kidney tissues from rats, RT-PCR was used (Fig. 1A) . A 2438 bp PCR ACE2 product was obtained consistently in four separate experiments and was confirmed by gene sequencing. No PCR products were detected in the negative control reaction using a cDNA template 'synthesized' without reverse transcriptase.
PANCREATIC ACE2 PROTEIN MEASURED BY IMMUNOBLOTTING
Immunoblotting analysis using rabbit polyclonal antibody against the C-terminal region of ACE2 was performed to confirm levels of ACE2 protein in the rat pancreas. As shown in Fig. 1B , the antibody recognized a single 92 kDa band in the total protein extract indicative of ACE2 protein, whereas the negative control showed no significant bands.
PANCREATIC ACE2 PROTEIN MEASURED BY IMMUNOHISTOCHEMISTRY
Immunohistochemistry was used to examine levels of ACE2 protein in pancreatic tissue. Haematoxylin and eosin (H&E) staining ( Fig.  2A) allowed the exocrine and endocrine pancreatic tissues to be clearly distinguished. Compared with the negative control ( Fig.  2B) , where sections were incubated in PBS without the primary antibody to ACE2, Fig.  2C clearly shows that ACE2 protein was present in both exocrine and endocrine HJ Fang, JK Yang Pancreatic expression of angiotensin-converting enzyme 2 pancreatic tissues. The acinar pancreatic cells displayed weaker staining than the islets of Langerhans.
PANCREATIC ACE2 PROTEIN MEASURED BY IMMUNOELECTRON MICROSCOPY
The existence of ACE2 enzymes in the pancreas was further demonstrated by immunoelectron microscopy. ACE2 protein expression was detected by labelling with 10 nm gold-conjugated goat antirabbit IgG. A punctate staining pattern of ACE2 expression was localized to both the endocrine and exocrine tissue of the rat pancreas. In the sections of pancreatic islets of Langerhans, specific immunoreactivity was found in the membranes of the secretory granules and the cytoplasmic membranes (Fig. 3A) . In the sections incubated with control sera, no specific immunoreactivity was observed (Fig.  3B ). In the exocrine pancreas, gold particles were clearly localized on the mitochondria and endoplasmic reticulum (Fig. 3C) , and positive immunoreactivity was found in the secretory granules (Fig. 3D) . The pancreas is both an exocrine and endocrine gland; the endocrine portion (pancreatic islets of Langerhans) contains four major cell types that secrete specific hormones (insulin, glucagon, somatostatin and pancreatic polypeptide). After confirming the presence of ACE2 protein in the pancreatic islets, further studies were undertaken to identify the type of cell that was ACE2immunoreactive. 
DOUBLE-IMMUNOFLUORESCENCE LABELLING OF ACE2 PROTEIN IN ISLETS OF LANGERHANS
Double immunofluorescence labelling and laser scanning confocal microscopy studies were performed using antibodies against glucagon, insulin, somatostatin and pancreatic polypeptide as α-, β-, δand PPcell markers, respectively, together with anti-ACE2 polyclonal antibodies (Fig. 4) . The results clearly indicated that all insulincontaining β-cells abundantly expressed ACE2 (Fig. 4B4) . Some somatostatin-positive δ-cells also exhibited ACE2 immunoreactivity (Fig. 4C4 ), whereas ACE2 protein was absent from most of the glucagon-containing α-cells ( Fig. 4A4) and pancreatic polypeptide-containing PP-cells (Fig. 4D4) . Double staining revealed that both ACE2 and somatostatin or insulin were widely distributed in the islet of Langerhans and their immunostaining patterns were quite similar (Figs 4B, 4C) . Although cells immunoreactive for glucagon and pancreatic polypeptide were localized to the islets, they were rarely co-localized with ACE2-positive cells (Figs 4A, 4D) . Sections of the pancreas were prepared from five different rats and almost identical results were obtained from each rat.
Discussion
The present study suggests that the local RAS system within the pancreas is more complex than currently thought, as shown by the discovery that the functional component, ACE2, is expressed in the pancreatic islets of Langerhans in the rat. ACE2, acting as a FIGURE 2: Evaluation of angiotensinconverting enzyme 2 (ACE2) protein levels in the pancreas, as assessed by immunohistochemistry. (A) Haematoxylin and eosin staining shows the exocrine tissue of the pancreas (red) with a pancreatic islet in the middle. (B) Negative control where phosphate-buffered saline was substituted for the primary antibody to exclude nonspecific staining, particularly that caused by endogenous biotin. (C) Shows that ACE2 protein in the pancreas was localized to both the exocrine and endocrine tissues; staining for ACE2 protein was stronger in the pancreatic islets of Langerhans than in the exocrine tissues A C B HJ Fang, JK Yang Pancreatic expression of angiotensin-converting enzyme 2 negative regulator for RAS by converting angiotensin II to angiotensin 1-7, can effectively antagonize the generation of angiotensin II, which provides a rationale for the further exploration of its role in pathophysiological states, including myocardial ischaemia, hypertension, heart failure, renal failure, atherosclerosis and diabetic complications. 14 -19 A local RAS system was discovered in pancreatic tissue in 2001 and was shown to be involved in remodelling of the tissue infrastructure, as demonstrated by the fact that the over-expression of RAS was able to rejuvenate previously damaged pancreatic tissue. 20 ACE2, a fairly recently discovered component of RAS, might play an important role in this process. 21 to be involved in the pathogenesis of diabetes. 22 
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recent meta-analysis of clinical trials of ACE inhibitors and angiotensin receptor blockers was conducted in order to evaluate their protective effects. 24 The meta-analysis concluded that the mean risk for developing type 2 diabetes mellitus was reduced by 27% with ACE inhibitor treatments, 23% with angiotensin receptor blockers and 25% overall in a pooled analysis of these two RAS blockers. 24 The discovery of ACE2 has opened up an exciting new area of study concerning diabetes mellitus and its complications, and has provided the opportunity to identify several novel therapeutic targets.
In order to understand the pathophysiology of ACE2 in diabetes mellitus and its complications, knowledge of the possible expression and cell distribution of ACE2 protein within the pancreatic tissues, particularly in the endocrine pancreas, is required. In the present study, RT-PCR, immunoblotting and immunohistochemistry analyses demonstrated that ACE2 protein was present in the rat pancreas and, using immunoelectron microscopy, it was found that ACE2 protein was localized in the secretory granules of the pancreatic islets of Langerhans. Double immunofluorescence labelling results revealed that ACE2 was localized to the endocrine region of the islet of Langerhans, both in the insulincontaining β-cells and the somatostatinpositive δ-cells.
The discovery that ACE2 is expressed in the pancreatic islet cells provides a better understanding of the pathogenesis of pancreatic lesions in severe acute respiratory syndrome (SARS) patients. In addition to its physiological function as a carboxypeptidase, ACE2 is used by the SARS coronavirus as a co-receptor. 25 Some autopsies of deceased SARS patients showed pancreatic lesions and SARS coronavirus has been directly detected in pancreatic acinar cells from deceased SARS patients. 26 Although increasing excretion of glucoseelevating hormones is caused by infection, fever and oxygen deficiency, or so called 'stress', may also contribute. SARS coronavirus may invade the exocrine tissue of the pancreas causing an inflammatory reaction (pancreatitis) which, in turn, induces hyperglycaemia. In clinical practice, many patients with acute pancreatitis do not present with raised blood glucose levels in the acute stages. There are almost no reports of pancreatitis in patients with SARS. The localization of ACE2 expression in the endocrine part of the pancreas suggests that SARS coronavirus enters the islets of Langerhans using ACE2 as its receptor and damages the islets, thereby causing acute diabetes. 27 This is consistent with the finding from the present study that the pancreatic islets of Langerhans were strongly immunoreactive for ACE2 while the pancreatic exocrine tissues were only weakly positive.
In summary, regardless of any speculation on the pathophysiological role of ACE2 in pancreatic islet of Langerhans cells, the present study unambiguously demonstrated that β and δ islet cells in the rat were strongly positive for ACE2 protein.
These findings should prove to be of significant interest to a number of research groups interested in characterizing the physiological function and pathophysiological role of ACE2 in a number of diseases.
